( en | de | ru )

 

Disambiguation of "Gøtzsche, Peter C"

Author of the publication

copydeleteadd this publication to your clipboard
Lessons from and cautions about noninferiority and equivalence randomized trials.

. JAMA : the journal of the American Medical Association, 295 (10): 1172-4 (March 2006)4378<m:linebreak></m:linebreak>LR: 20071115; PUBM: Print; JID: 7501160; CON: JAMA. 2006 Mar 8;295(10):1147-51. PMID: 16522835; CON: JAMA. 2006 Mar 8;295(10):1152-60. PMID: 16522836; ppublish;<m:linebreak></m:linebreak>Tests d&#039;equivalència.
DOI: 10.1001/jama.295.10.1172

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

C -Peter Fagerstroem

Peter C Baumann

Peter C Matt

Peter C Erb

Peter C Bloth

 

Other publications of authors with the same name

Ghost Authorship in Industry-Initiated Randomised Trials. PLoS Medicine, (2006)Is screening for breast cancer with mammography justifiable?, and . The Lancet, 355 (9198): 129 - 134 (2000)Opening up data at the European Medicines Agency, , , and . BMJ, (2011)Opening up data at the European Medicines Agency, and . BMJ, (May 10, 2011)The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations., , , , , , , , , and 7 other author(s). Annals of internal medicine, 162 (11): 777-84 (June 2015)Publicació; Network meta-analysis.Lessons from and cautions about noninferiority and equivalence randomized trials.. JAMA : the journal of the American Medical Association, 295 (10): 1172-4 (March 2006)4378<m:linebreak></m:linebreak>LR: 20071115; PUBM: Print; JID: 7501160; CON: JAMA. 2006 Mar 8;295(10):1147-51. PMID: 16522835; CON: JAMA. 2006 Mar 8;295(10):1152-60. PMID: 16522836; ppublish;<m:linebreak></m:linebreak>Tests d&#039;equivalència.Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration., , , , , , , , and . Gaceta sanitaria / S.E.S.P.A.S, 23 (2): 158 (2009)5153<m:linebreak></m:linebreak>JID: 8901623; 2009/02/26 aheadofprint; ppublish;<m:linebreak></m:linebreak>Publicació.Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review., , , , and . BMJ (Clinical research ed.), (January 2010)5713<m:linebreak></m:linebreak>JID: 8900488; CIN: BMJ. 2010;341:c3529. PMID: 20719822; OID: NLM: PMC2923692; epublish;<m:linebreak></m:linebreak>Comparacions múltiples; Composite endpoints.What Should Be Done To Tackle Ghostwriting in the Medical Literature?, , , , , , and . PLoS Med, 6 (2): e1000023+ (February 2009)Believability of relative risks and odds ratios in abstracts: cross sectional study.. BMJ (Clinical research ed.), 333 (7561): 231-4 (July 2006)4383<m:linebreak></m:linebreak>LR: 20071115; PUBM: Print-Electronic; DEP: 20060719; JID: 8900488; PMC1523498; 2006/07/19 aheadofprint; ppublish;<m:linebreak></m:linebreak>Presentació de dades.